Amend the Committee amendment, as and if amended, page [4803-100 by striking lines 13-19 and inserting:
/ (B) The principal investigator and any subinvestigator may receive cannabidiol directly from an approved source or authorized distributor for an approved source for use in the expanded access clinical trials. /
Amend the bill further, page [4803-11] by striking lines 13-15 and inserting:
/ (i) the President or a designee of the Medical University of South Carolina;
(j) the President or a designee of Clemson University; and
(k) the President or a designee of the South Carolina Medical Association. /
Renumber sections to conform.
Amend title to conform.